Yongsheng Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yongsheng Zhang has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Zhifei Cao
The Second Affiliated Hospital of Soochow University
4 shared publications Jun Zhang
The Second Affiliated Hospital of Soochow University
3 shared publicationsMengmeng Xu
Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou, China
3 shared publicationsTianyu Yang
Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou, China
3 shared publicationsXinyang Cheng
The Second Affiliated Hospital of Soochow University
3 shared publicationsBao-Zhu Liu
Collaborative Innovation Center of Clinical Immunology Between Soochow University and Sihong People’s Hospital, Sihong 223900, China
2 shared publications
Latest Publications
- Open Access
- 16 April 2026
- Published by SAGE Publications in Dose-Response
- Vol. 24 (2)
Characterization of the Intestinal Metabolic Profiles Following Photon FLASH Irradiation
Objective: Ultra-high dose rate radiotherapy, commonly referred to as FLASH radiotherapy, is a transformative focus in radiotherapeutic research. This study aimed to identify intestinal contents based metabolic biomarkers of photon FLASH. Methods: C57BL/6J mice were exposed to 0 Gy, 10 Gy, 12 Gy, or 14 Gy of photon FLASH irradiation (FLASH-IR) without a conventional irradiation. The intestinal contents were collected 3.5 d post-iiradiation, and subjected to liquid chromatography-mass spectrometry. Results: Metabolomic profiling revealed 25 differential metabolites that were consistently differentially regulated across the comparisons of 10 Gy vs. 0 Gy, 12 Gy vs. 0 Gy, and 14 Gy vs. 0 Gy groups. Notably, a dose-dependent positive correlation was observed for 3-hydroxyanthranilate, while 13 metabolites—including guanosine, adenosine monophosphate, and hydroquinone—exhibited a significant negative correlation with increasing FLASH-IR dose. Further enrichment analysis identified several perturbed metabolic cascades, prominently involving the PI3K-AKT signaling pathway, tyrosine metabolism, and purine metabolism. Conclusions: These findings illuminated the intestinal metabolic signatures post photon FLASH-IR, offering insights to optimize FLASH radiotherapy parameters and enhance its therapeutic ratio.
- 16 April 2026
- Published by SAGE Publications in Dose-Response
- Vol. 24 (2)
Open AccessCharacterization of the Intestinal Metabolic Profiles Following Photon FLASH Irradiation
Objective: Ultra-high dose rate radiotherapy, commonly referred to as FLASH radiotherapy, is a transformative focus in radiotherapeutic research. This study aimed to identify intestinal contents based metabolic biomarkers of photon FLASH. Methods: C57BL/6J mice were exposed to 0 Gy, 10 Gy, 12 Gy, or 14 Gy of photon FLASH irradiation (FLASH-IR) without a conventional irradiation. The intestinal contents were collected 3.5 d post-iiradiation, and subjected to liquid chromatography-mass spectrometry. Results: Metabolomic profiling revealed 25 differential metabolites that were consistently differentially regulated across the comparisons of 10 Gy vs. 0 Gy, 12 Gy vs. 0 Gy, and 14 Gy vs. 0 Gy groups. Notably, a dose-dependent positive correlation was observed for 3-hydroxyanthranilate, while 13 metabolites—including guanosine, adenosine monophosphate, and hydroquinone—exhibited a significant negative correlation with increasing FLASH-IR dose. Further enrichment analysis identified several perturbed metabolic cascades, prominently involving the PI3K-AKT signaling pathway, tyrosine metabolism, and purine metabolism. Conclusions: These findings illuminated the intestinal metabolic signatures post photon FLASH-IR, offering insights to optimize FLASH radiotherapy parameters and enhance its therapeutic ratio.
- Open Access
- 22 March 2026
- Published by Springer Nature in Discover Oncology
- Vol. 17
Research progresses on FLASH radiotherapy and its application for the treatment of digestive system tumors
Over the past decades, advances in technique have turned radiotherapy into a precise and effective modality for cancer treatment. Nevertheless, the biological effect on organs surrounding the tumor target area is a main dose-limiting element in radiotherapy, e.g., doses are restricted by lethal intestinal tissue toxicity for many pelvic or abdominal cancer radiotherapy. Consequently, minimizing the damage to normal tissues has become a focal point in radiotherapy research. Recently, ionizing radiation delivered at ultra-high dose rates (also termed FLASH-RT) has emerged in the field. Preclinical studies in a variety of animal models have shown that FLASH-RT can control tumors while minimizing normal tissue toxicity compared to conventional radiotherapy (CONV-RT), which broadens the therapeutic window of radiotherapy. In this review, we summarize the present speculations on the biological mechanisms underlying the FLASH effects, including oxygen depletion hypothesis, mitochondria hypothesis, genome stability hypothesis, immunomodulation hypothesis, and so on. Furthermore, we summarize the main data supporting the clinical translation of FLASH-RT, and discuss its relevance and applicability in the treatment of digestive system tumors.
- 22 March 2026
- Published by Springer Nature in Discover Oncology
- Vol. 17
Open AccessResearch progresses on FLASH radiotherapy and its application for the treatment of digestive system tumors
Over the past decades, advances in technique have turned radiotherapy into a precise and effective modality for cancer treatment. Nevertheless, the biological effect on organs surrounding the tumor target area is a main dose-limiting element in radiotherapy, e.g., doses are restricted by lethal intestinal tissue toxicity for many pelvic or abdominal cancer radiotherapy. Consequently, minimizing the damage to normal tissues has become a focal point in radiotherapy research. Recently, ionizing radiation delivered at ultra-high dose rates (also termed FLASH-RT) has emerged in the field. Preclinical studies in a variety of animal models have shown that FLASH-RT can control tumors while minimizing normal tissue toxicity compared to conventional radiotherapy (CONV-RT), which broadens the therapeutic window of radiotherapy. In this review, we summarize the present speculations on the biological mechanisms underlying the FLASH effects, including oxygen depletion hypothesis, mitochondria hypothesis, genome stability hypothesis, immunomodulation hypothesis, and so on. Furthermore, we summarize the main data supporting the clinical translation of FLASH-RT, and discuss its relevance and applicability in the treatment of digestive system tumors.
- Top Cited PapersOpen Access
- 22 January 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1) , 62
Engineering bacteriophages for gut health: precision antimicrobials and beyond
Engineered bacteriophages are emerging as a promising class of precision antimicrobials at a time when gastrointestinal diseases are increasingly linked to
- 22 January 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1) , 62
Top Cited PapersOpen AccessEngineering bacteriophages for gut health: precision antimicrobials and beyond
Engineered bacteriophages are emerging as a promising class of precision antimicrobials at a time when gastrointestinal diseases are increasingly linked to
- Open Access
- 1 July 2025
- Published by SAGE Publications in Dose-Response
- Vol. 23 (3)
Efficacy of Radiotherapy FLASH-RT: From Treating Lung Cancer to Preventing Pulmonary Fibrosis
FLASH radiotherapy (FLASH-RT) is a radiotherapy technique that achieves ultra-high dose rates in a fraction of a second. Based on data from experimental animal models, FLASH-RT appears to protect a number of normal tissues from radiation-induced damage, including the brain, gastrointestinal tract, and lung, while conventional radiotherapy (CONV-RT) causes radiation-induced toxicity in these tissues. In this review, we provide a brief summary of the history of radiation therapy and focus on some of the most recent FLASH-RT papers and findings. It is particularly noteworthy that pulmonary fibrosis represents a common complication of radiotherapy. New evidence indicates that FLASH-RT, unlike traditional radiotherapy methods, might help protect lung cancer patients from developing pulmonary fibrosis caused by radiation. FLASH-RT will advance more quickly than anticipated, although there are still a number of unresolved concerns. FLASH-RT will be a safer and more effective option for lung cancer treatment.
- 1 July 2025
- Published by SAGE Publications in Dose-Response
- Vol. 23 (3)
Open AccessEfficacy of Radiotherapy FLASH-RT: From Treating Lung Cancer to Preventing Pulmonary Fibrosis
FLASH radiotherapy (FLASH-RT) is a radiotherapy technique that achieves ultra-high dose rates in a fraction of a second. Based on data from experimental animal models, FLASH-RT appears to protect a number of normal tissues from radiation-induced damage, including the brain, gastrointestinal tract, and lung, while conventional radiotherapy (CONV-RT) causes radiation-induced toxicity in these tissues. In this review, we provide a brief summary of the history of radiation therapy and focus on some of the most recent FLASH-RT papers and findings. It is particularly noteworthy that pulmonary fibrosis represents a common complication of radiotherapy. New evidence indicates that FLASH-RT, unlike traditional radiotherapy methods, might help protect lung cancer patients from developing pulmonary fibrosis caused by radiation. FLASH-RT will advance more quickly than anticipated, although there are still a number of unresolved concerns. FLASH-RT will be a safer and more effective option for lung cancer treatment.
- Open Access
- 2 June 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-14
Berbamine inhibits cell proliferation and invasion by increasing FTO expression in renal cell carcinoma cells
Berbamine (BBM) has been reported to play an important role in the anti-inflammatory and anti-neoplastic activities. However, whether BBM mediates the anti-tumor efficacy in renal cell carcinoma (RCC) cells and the potential molecular mechanisms remain unclear. The effects of BBM on the proliferation, colony formation, cell cycle, cell migration and invasion abilities were performed in RCC cells 786-O and OSRC2, and the effect of BBM on tumor formation was further explored. Furthermore, the effects of BBM on the expression of fat mass and obesity associated gene (FTO) and its target genes were investigated. Finally, the effects of BBM on the proliferation, and invasion of RCC cells after knockdown of FTO were detected. BBM effectively inhibited the proliferation, migration and invasion of RCC cells in a dose-dependent manner, and BBM also significantly inhibited the growth of tumor in vivo, which has fewer toxic effects on the other organs. Molecular mechanistic studies showed that BBM significantly promoted the expression of FTO mRNA and protein in RCC cells, and knock-down of FTO by siRNA transfection reversed the inhibitory effect of BBM on the growth and invasion of RCC cells. Collectively, our findings revealed that targeting the tumor suppressive FTO by BBM is a new option to inhibit RCC cells growth and metastasis, providing a good drug candidate potential for development novel therapeutics against metastatic RCC.
- 2 June 2025
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-14
Open AccessBerbamine inhibits cell proliferation and invasion by increasing FTO expression in renal cell carcinoma cells
Berbamine (BBM) has been reported to play an important role in the anti-inflammatory and anti-neoplastic activities. However, whether BBM mediates the anti-tumor efficacy in renal cell carcinoma (RCC) cells and the potential molecular mechanisms remain unclear. The effects of BBM on the proliferation, colony formation, cell cycle, cell migration and invasion abilities were performed in RCC cells 786-O and OSRC2, and the effect of BBM on tumor formation was further explored. Furthermore, the effects of BBM on the expression of fat mass and obesity associated gene (FTO) and its target genes were investigated. Finally, the effects of BBM on the proliferation, and invasion of RCC cells after knockdown of FTO were detected. BBM effectively inhibited the proliferation, migration and invasion of RCC cells in a dose-dependent manner, and BBM also significantly inhibited the growth of tumor in vivo, which has fewer toxic effects on the other organs. Molecular mechanistic studies showed that BBM significantly promoted the expression of FTO mRNA and protein in RCC cells, and knock-down of FTO by siRNA transfection reversed the inhibitory effect of BBM on the growth and invasion of RCC cells. Collectively, our findings revealed that targeting the tumor suppressive FTO by BBM is a new option to inhibit RCC cells growth and metastasis, providing a good drug candidate potential for development novel therapeutics against metastatic RCC.
- Open Access
- 1 April 2025
- Published by SAGE Publications in Dose-Response
- Vol. 23 (2)
Comparative Transcriptomic Analysis Unveils Divergent Effects of FLASH Versus Conventional Irradiation on Skin Cells
Objectives: FLASH radiotherapy is garnering attention for its capacity to diminish skin toxicity without compromising tumoricidal efficacy, presenting a stark contrast to conventional (CONV) radiotherapy. Despite its promise, the underlying molecular mechanisms of FLASH irradiation (FLASH-IR) on skin are not yet fully elucidated. Methods: This study investigated the transcriptomic responses of human foreskin fibroblast cells (HFF-1) via the FLASH-IR or CONV irradiation (CONV-IR), employing the next-generation RNA sequencing (RNA-seq) to capture the gene expression profiles. Our comparative analysis aimed to dissect the cellular and molecular pathways influenced by these two irradiation methods. Results: We identified a spectrum of differentially expressed genes (DEGs), signaling pathways, and transcriptional networks that were either shared or divergent between FLASH-IR and CONV-IR. Particularly, transcription factor NR4A1 showed significant upregulation in response to FLASH-IR, while chromatin stability factor ELF3 was markedly downregulated following CONV-IR. The top 10 up-regulated DEGs were subjected to qPCR validation, confirming their differential expression in response to FLASH-IR and CONV-IR. Conclusion: Collectively, our findings delineate unique regulatory landscapes of FLASH-IR and CONV-IR on skin cells, corroborating established effects and shedding new light on the molecular interplay within the context of ultra-high dose radiation.
- 1 April 2025
- Published by SAGE Publications in Dose-Response
- Vol. 23 (2)
Open AccessComparative Transcriptomic Analysis Unveils Divergent Effects of FLASH Versus Conventional Irradiation on Skin Cells
Objectives: FLASH radiotherapy is garnering attention for its capacity to diminish skin toxicity without compromising tumoricidal efficacy, presenting a stark contrast to conventional (CONV) radiotherapy. Despite its promise, the underlying molecular mechanisms of FLASH irradiation (FLASH-IR) on skin are not yet fully elucidated. Methods: This study investigated the transcriptomic responses of human foreskin fibroblast cells (HFF-1) via the FLASH-IR or CONV irradiation (CONV-IR), employing the next-generation RNA sequencing (RNA-seq) to capture the gene expression profiles. Our comparative analysis aimed to dissect the cellular and molecular pathways influenced by these two irradiation methods. Results: We identified a spectrum of differentially expressed genes (DEGs), signaling pathways, and transcriptional networks that were either shared or divergent between FLASH-IR and CONV-IR. Particularly, transcription factor NR4A1 showed significant upregulation in response to FLASH-IR, while chromatin stability factor ELF3 was markedly downregulated following CONV-IR. The top 10 up-regulated DEGs were subjected to qPCR validation, confirming their differential expression in response to FLASH-IR and CONV-IR. Conclusion: Collectively, our findings delineate unique regulatory landscapes of FLASH-IR and CONV-IR on skin cells, corroborating established effects and shedding new light on the molecular interplay within the context of ultra-high dose radiation.
- Open Access
- 25 October 2023
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 11, 1265290
Adsorption performance and mechanism of Li+ from brines using lithium/aluminum layered double hydroxides-SiO2 bauxite composite adsorbents
A combined method of solid-phase alkali activation and surface precipitation was used to prepare the lithium/aluminum layered double hydroxides-SiO2 loaded bauxite (LDH-Si-BX) and applied to adsorb Li+ in brines. In the study, various characterization techniques such as SEM, XRD, BET, Zeta potential, and x-ray photoelectron spectroscopy (XPS) were applied to characterize and analyze the adsorbents. The adsorption-desorption performance of LDH-Si-BX for Li+ in brines was systematically investigated, including adsorption temperature, adsorption time, Li+ concentration, and regeneration properties. The results indicated that the adsorption kinetics were better fitted by the pseudo-second-order model, whereas the Langmuir model could match the adsorption isotherm data and the maximum Li+ capacity of 1.70 mg/g at 298K. In addition, in the presence of coexisting ions (Na+, K+, Ca2+, and Mg2+), LDH-Si-BX showed good selective adsorption of Li+, and the pH studies demonstrated that the adsorbents had better Li+ adsorption capacity in neutral environments. In the adsorption process of real brines, LDH-Si-BX had a relatively stable adsorption capacity, and after 10 cycles of adsorption and regeneration, the adsorption capacity decreased by 16.8%. It could be seen that the LDH-Si-BX adsorbents prepared in this report have the potential for Li+ adsorption in brines.
- 25 October 2023
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 11, 1265290
Open AccessAdsorption performance and mechanism of Li+ from brines using lithium/aluminum layered double hydroxides-SiO2 bauxite composite adsorbents
A combined method of solid-phase alkali activation and surface precipitation was used to prepare the lithium/aluminum layered double hydroxides-SiO2 loaded bauxite (LDH-Si-BX) and applied to adsorb Li+ in brines. In the study, various characterization techniques such as SEM, XRD, BET, Zeta potential, and x-ray photoelectron spectroscopy (XPS) were applied to characterize and analyze the adsorbents. The adsorption-desorption performance of LDH-Si-BX for Li+ in brines was systematically investigated, including adsorption temperature, adsorption time, Li+ concentration, and regeneration properties. The results indicated that the adsorption kinetics were better fitted by the pseudo-second-order model, whereas the Langmuir model could match the adsorption isotherm data and the maximum Li+ capacity of 1.70 mg/g at 298K. In addition, in the presence of coexisting ions (Na+, K+, Ca2+, and Mg2+), LDH-Si-BX showed good selective adsorption of Li+, and the pH studies demonstrated that the adsorbents had better Li+ adsorption capacity in neutral environments. In the adsorption process of real brines, LDH-Si-BX had a relatively stable adsorption capacity, and after 10 cycles of adsorption and regeneration, the adsorption capacity decreased by 16.8%. It could be seen that the LDH-Si-BX adsorbents prepared in this report have the potential for Li+ adsorption in brines.
- 18 September 2023
- Published by Elsevier in Chemical Engineering Journal
- Vol. 475, 146144
Synergy of electronic and steric effects of Br-Ni catalysts for selective hydrogenolysis of diphenyl ether to phenol
- 18 September 2023
- Published by Elsevier in Chemical Engineering Journal
- Vol. 475, 146144
Synergy of electronic and steric effects of Br-Ni catalysts for selective hydrogenolysis of diphenyl ether to phenol
- RetractionOpen Access
- 14 October 2022
- Published by Medknow in Asian Journal of Andrology
- Vol. 24 (6) , 684
Retraction note: TGF-β1-regulated miR-3691-3p targets E2F3 and PRDM1 to inhibit prostate cancer progression
- 14 October 2022
- Published by Medknow in Asian Journal of Andrology
- Vol. 24 (6) , 684
RetractionOpen AccessRetraction note: TGF-β1-regulated miR-3691-3p targets E2F3 and PRDM1 to inhibit prostate cancer progression
- Open Access
- 22 August 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 950213
CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma via M2 macrophage interactions: A bioinformatic analysis of the tumor microenvironment
Backgrounds: Prior investigations of the tumor microenvironment (TME) of diffuse large B-cell lymphoma (DLBCL) have shown that immune and stromal cells are key contributing factors to patients’ outcome. However, challenges remain in finding reliable prognostic biomarkers based on cell infiltration. In this study, we attempted to shed some light on chemokine C–C motif chemokine ligand 8 (CCL8) in DLBCL via interaction with M2 macrophages.Methods: The Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data (ESTIMATE) algorithm was applied to evaluate immune and stromal scores from transcriptomic profiles of 443 DLBCL samples from The Cancer Genome Atlas (TCGA) and GSE10846 datasets. Immune cell infiltration (ICI) clusters were obtained based on different immune cell infiltrations of each sample, and gene clusters were derived through differentially expressed genes (DEGs) between the distinct ICI clusters. Five immune-related hub genes related to overall survival (OS) and clinical stages were obtained by COX regression analysis and protein–protein interaction (PPI) network construction then verified by quantitative real-time PCR (qPCR) and immunofluorescence staining in the FFPE tissues. The Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and TIMER websites were employed to explore the biological functions of CCL8-related DEGs. Uni- and multivariable Cox regression analyses were performed to analyze CCL8 as an independent prognostic risk factor in GSE10846 and were verified in other independent GEO cohorts.Results: A higher stromal score was associated with favorable prognosis in DLBCL. Patients in the ICI B cluster and gene B clusters had a better follow-up status with a higher programmed death ligand 1 (PD-L1) and cytotoxic T-lymphocyte antigen 4 (CTLA4) expression. Most of ICI-related DEGs were enriched for immune-related signaling pathways. Five hub genes with a distinct prognosis association were identified, including CD163, which is a biomarker of M2 macrophages, and CCL8. Abundant M2 macrophages were discovered in the high-CCL8 expression group. The functional analysis indicated that CCL8 is a key component of immune-related processes and secretory granule groups. Cox regression analysis and data from other GSE datasets yielded additional evidence of the prognostic value of CCL8 in DLBCL.Conclusions: CCL8 has been implicated in macrophage recruitment in several solid tumors, and only a few reports have been published on the role of CCL8 in the pathogenesis of hematological malignancies. This article attempted to find out TME-related genes that associated with the survival in DLBCL patients. CCL8 was identified to be involved in immune activities. Importantly, a series of bioinformatics analysis indicated that CCL8 might become an effective target for DLBCL, which interacts with M2 macrophage and immune checkpoint. The potential related mechanisms need to be further elucidated.
- 22 August 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 950213
Open AccessCCL8 as a promising prognostic factor in diffuse large B-cell lymphoma via M2 macrophage interactions: A bioinformatic analysis of the tumor microenvironment
Backgrounds: Prior investigations of the tumor microenvironment (TME) of diffuse large B-cell lymphoma (DLBCL) have shown that immune and stromal cells are key contributing factors to patients’ outcome. However, challenges remain in finding reliable prognostic biomarkers based on cell infiltration. In this study, we attempted to shed some light on chemokine C–C motif chemokine ligand 8 (CCL8) in DLBCL via interaction with M2 macrophages.Methods: The Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data (ESTIMATE) algorithm was applied to evaluate immune and stromal scores from transcriptomic profiles of 443 DLBCL samples from The Cancer Genome Atlas (TCGA) and GSE10846 datasets. Immune cell infiltration (ICI) clusters were obtained based on different immune cell infiltrations of each sample, and gene clusters were derived through differentially expressed genes (DEGs) between the distinct ICI clusters. Five immune-related hub genes related to overall survival (OS) and clinical stages were obtained by COX regression analysis and protein–protein interaction (PPI) network construction then verified by quantitative real-time PCR (qPCR) and immunofluorescence staining in the FFPE tissues. The Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and TIMER websites were employed to explore the biological functions of CCL8-related DEGs. Uni- and multivariable Cox regression analyses were performed to analyze CCL8 as an independent prognostic risk factor in GSE10846 and were verified in other independent GEO cohorts.Results: A higher stromal score was associated with favorable prognosis in DLBCL. Patients in the ICI B cluster and gene B clusters had a better follow-up status with a higher programmed death ligand 1 (PD-L1) and cytotoxic T-lymphocyte antigen 4 (CTLA4) expression. Most of ICI-related DEGs were enriched for immune-related signaling pathways. Five hub genes with a distinct prognosis association were identified, including CD163, which is a biomarker of M2 macrophages, and CCL8. Abundant M2 macrophages were discovered in the high-CCL8 expression group. The functional analysis indicated that CCL8 is a key component of immune-related processes and secretory granule groups. Cox regression analysis and data from other GSE datasets yielded additional evidence of the prognostic value of CCL8 in DLBCL.Conclusions: CCL8 has been implicated in macrophage recruitment in several solid tumors, and only a few reports have been published on the role of CCL8 in the pathogenesis of hematological malignancies. This article attempted to find out TME-related genes that associated with the survival in DLBCL patients. CCL8 was identified to be involved in immune activities. Importantly, a series of bioinformatics analysis indicated that CCL8 might become an effective target for DLBCL, which interacts with M2 macrophage and immune checkpoint. The potential related mechanisms need to be further elucidated.